Skip to main content
. 2020 May 21;15(5):e0233454. doi: 10.1371/journal.pone.0233454

Table 1. Pharmacologic treatment according to therapeutic group (ATC classification).

Therapeutic group Active ingredient
Benzodiazepines Alprazolam/Trankimazin, Bentazepam, Bromazepam, Clonazepam, Clorazepate Dipotassium, Diazepam, Midazolam, Ketazolam, Lorazepam, Lormetazepam, Medazepam, Piracetam, Tepazepam, Halazepam/Flurazepam
Selective Serotonin Reuptake Inhibitors (SSRIs) Citalopram, Escitalopram, Fluoxetine, Paroxetine, Sertraline, Fluvoxamine
Tricyclic Antidepressants (TCAs) Clomipramine, Imipramine, Amitriptyline, Tianeptine, Doxepine, Nortriptyline
Serotonin–norepinephrine reuptake inhibitors (SNRIs) Desvenlafaxine, Duloxetine, Venlafaxine
Norepinephrine reuptake inhibitors (NRIs) Reboxetine
Heterocycles Mianserin, Maprotiline
Noreprinephrine-dopamine reuptake inhibitors (NDRIs) Bupropion
Serotonin antagonist and reuptake inhibitors (SARIs) Trazodone
Noradrenergic and specific serotonergic antidepressants (NaSSAs) Mirtazapine
Melatonin receptor agonist (MRA) Agomelatine
Serotonin activity modulator (SMS) Vortioxetine
Hypnotics Zolpidem
Antiepileptic Topiramate
Typical Neuroleptics Levomepromazine, Haloperidol, Trifluoperazine
Atypical Neuroleptics Quetiapine, Risperidone, Olanzapine
Non-specific drugs Melitracen/flupentixol, Deanol/heptaminol, Vitamin B complex, Piridoxine/Sulbutiamine, Levosulpiride/sulpiride, Gabapentin